This inventor holds 1 USPTO granted patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Anthony Handlon
Introduction
Anthony Handlon is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on novel compounds that target specific medical conditions.
Latest Patents
One of Handlon's key inventions is related to MrgX2 antagonists. This invention pertains to novel compounds according to Formula (I), which serve as antagonists of MrgX2. The patent outlines pharmaceutical compositions containing these compounds and their therapeutic applications for treating MrgX2-mediated diseases and disorders. Handlon holds 1 patent for this innovative work.
Career Highlights
Anthony Handlon is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in pharmaceutical development. His work has contributed to advancements in medical treatments and has the potential to improve patient outcomes.
Collaborations
Throughout his career, Handlon has collaborated with talented individuals such as Michael Jonathan Bury and Rodolfo Cadilla. These partnerships have fostered a creative environment that encourages innovation and the development of new therapeutic solutions.
Conclusion
Anthony Handlon's contributions to the field of pharmaceuticals, particularly through his patent on MrgX2 antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies.